Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y
ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher ...
The Motley Fool on MSN23h
Alnylam Delivers a Big Q4 Earnings Beat
Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.
Zacks.com on MSN2h
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y
Ultragenyx Pharmaceutical RARE reported fourth-quarter 2024 loss of $1.39 per share, wider than the Zacks Consensus Estimate ...
Indiatimes17h
Maruti Suzuki Q4 results
Maruti Suzuki Q4 Results: The profit figure was higher than the Street estimate of Rs 3046 crore. The Board has also recommended a final dividend of Rs 125 per share for the financial year 2023-24.